SMTL ID : 4cd0.1

Structure of L1196M Mutant Human Anaplastic Lymphoma Kinase in Complex with 2-(5-(6-amino-5-((R)-1-(5-fluoro-2-(2H-1,2,3-triazol-2- yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propane-1,2-diol

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.23 Å

Oligo State

monomer

Ligands

1 x AWJ: (2R)-2-[5-(6-amino-5-{(1R)-1-[2-(1,3-dihydro-2H-1,2,3-triazol-2-yl)-5-fluorophenyl]ethoxy}pyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]propane-1,2-diol(Non-covalent)

AWJ.1: 17 residues within 4Å: Chain A: L.53, G.54, G.56, V.61, A.79, M.127, E.128, L.129, M.130, G.133, D.134, S.137, R.184, N.185, L.187, G.200, D.201 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.53, A:V.61, A:L.187, A:L.187 Hydrogen bonds: A:E.128, A:M.130, A:D.134, A:D.134, A:D.134, A:S.137 Water bridges: A:D.134 Halogen bonds: A:N.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, Q. et al., The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib. J.Med.Chem. (2014)

Release Date

2014-01-29

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence